HK1218387A1 - 使用乳酸菌的抗體效價提高劑 - Google Patents
使用乳酸菌的抗體效價提高劑Info
- Publication number
- HK1218387A1 HK1218387A1 HK16106384.3A HK16106384A HK1218387A1 HK 1218387 A1 HK1218387 A1 HK 1218387A1 HK 16106384 A HK16106384 A HK 16106384A HK 1218387 A1 HK1218387 A1 HK 1218387A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- lactic acid
- antibody titer
- acid bacterium
- increasing agent
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013175048 | 2013-08-26 | ||
PCT/JP2014/072229 WO2015029967A1 (ja) | 2013-08-26 | 2014-08-26 | 乳酸菌を用いた抗体価上昇剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1218387A1 true HK1218387A1 (zh) | 2017-02-17 |
Family
ID=52586524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16106384.3A HK1218387A1 (zh) | 2013-08-26 | 2016-06-03 | 使用乳酸菌的抗體效價提高劑 |
Country Status (10)
Country | Link |
---|---|
US (1) | US10195271B2 (zh) |
EP (1) | EP3040083B1 (zh) |
JP (1) | JP6449771B2 (zh) |
CN (1) | CN105555307A (zh) |
AU (1) | AU2014313030B2 (zh) |
CA (1) | CA2921820C (zh) |
HK (1) | HK1218387A1 (zh) |
NZ (1) | NZ717369A (zh) |
SG (2) | SG10201810886YA (zh) |
WO (1) | WO2015029967A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6713751B2 (ja) * | 2015-10-26 | 2020-06-24 | キリンホールディングス株式会社 | 抗原に対する特異的な細胞傷害性t細胞(ctl)及び抗体産生を増強させる方法 |
JP6777911B2 (ja) * | 2016-08-17 | 2020-10-28 | 株式会社明治 | 抗インフルエンザ薬による獲得免疫機能低下抑制用発酵乳およびその製造方法 |
JP7065589B2 (ja) * | 2017-10-31 | 2022-05-12 | 株式会社明治 | IL-1β血清濃度低下用発酵乳、CXCL1血清濃度低下用発酵乳、癌に伴うIL-1βの過度な血清濃度上昇の抑制用発酵乳、または、癌に伴うCXCL1の過度な血清濃度上昇の抑制用発酵乳 |
US20220362303A1 (en) * | 2021-02-26 | 2022-11-17 | Pantheryx, Inc. | Stabilized colostrum compositions |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2911057B2 (ja) | 1991-01-18 | 1999-06-23 | 高砂香料工業株式会社 | 感染防御剤及び感染防御効果を有する機能性食品 |
JP3805572B2 (ja) * | 1999-07-27 | 2006-08-02 | 大和製罐株式会社 | 押し潰し容易なプラスチックボトル |
JP5177728B2 (ja) | 2003-12-12 | 2013-04-10 | 株式会社明治 | Nk細胞活性化剤 |
JP3975361B2 (ja) * | 2004-03-08 | 2007-09-12 | 愛媛県 | 抗ストレプトコッカスサーモフィラスモノクローナル抗体、その産生細胞、ストレプトコッカスサーモフィラスの検出方法及び検出試薬 |
WO2006088923A2 (en) | 2005-02-15 | 2006-08-24 | Gorbach Sherwood L | A food containing a probiotic and an isolated beta-glucan and methods of use thereof |
FR2912657B1 (fr) * | 2007-02-16 | 2009-04-17 | Gervais Danone Sa | Utilisation de lactobacillus casei pour renforcer la protection induite par la vaccination anti-grippale. |
CN102647991B (zh) * | 2009-11-25 | 2015-05-06 | 株式会社明治 | 抗病毒剂和饮食品组合物 |
JP5242855B2 (ja) | 2010-07-29 | 2013-07-24 | 国立大学法人北海道大学 | 免疫アジュバント |
WO2012049301A1 (en) | 2010-10-15 | 2012-04-19 | Chr. Hansen A/S | Immunoadjuvant |
-
2014
- 2014-08-26 WO PCT/JP2014/072229 patent/WO2015029967A1/ja active Application Filing
- 2014-08-26 SG SG10201810886YA patent/SG10201810886YA/en unknown
- 2014-08-26 AU AU2014313030A patent/AU2014313030B2/en active Active
- 2014-08-26 JP JP2015534213A patent/JP6449771B2/ja active Active
- 2014-08-26 EP EP14839476.0A patent/EP3040083B1/en active Active
- 2014-08-26 US US14/914,382 patent/US10195271B2/en active Active
- 2014-08-26 CA CA2921820A patent/CA2921820C/en active Active
- 2014-08-26 SG SG11201601185YA patent/SG11201601185YA/en unknown
- 2014-08-26 NZ NZ717369A patent/NZ717369A/en unknown
- 2014-08-26 CN CN201480047180.7A patent/CN105555307A/zh active Pending
-
2016
- 2016-06-03 HK HK16106384.3A patent/HK1218387A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN105555307A (zh) | 2016-05-04 |
EP3040083B1 (en) | 2018-11-21 |
AU2014313030B2 (en) | 2017-01-19 |
US10195271B2 (en) | 2019-02-05 |
CA2921820A1 (en) | 2015-03-05 |
JP6449771B2 (ja) | 2019-01-09 |
JPWO2015029967A1 (ja) | 2017-03-02 |
SG10201810886YA (en) | 2019-01-30 |
AU2014313030A1 (en) | 2016-04-07 |
EP3040083A4 (en) | 2017-01-18 |
CA2921820C (en) | 2021-10-12 |
NZ717369A (en) | 2017-11-24 |
SG11201601185YA (en) | 2016-03-30 |
WO2015029967A1 (ja) | 2015-03-05 |
EP3040083A1 (en) | 2016-07-06 |
US20160206733A1 (en) | 2016-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202005525B (en) | Antibody formulations | |
IL244712B (en) | Anti- pdl1 antibody compositions | |
IL240754A0 (en) | Low concentration antibody compositions | |
HK1218549A1 (zh) | 新型抗體框架 | |
EP2832859A4 (en) | BACTERIA INDUCING DIABETES | |
HK1220454A1 (zh) | 吡啶- -基衍生物 | |
SG11201604537UA (en) | Implantable biosensor | |
EP2881459A4 (en) | NEW LACTIC BACTERIA | |
GB201601669D0 (en) | Biosensor | |
ZA201509182B (en) | Composition comprising a buffered lactic acid | |
HK1219961A1 (zh) | 人抗α型干擾素抗體 | |
EP2980573A4 (en) | BIOSENSOR | |
HK1218387A1 (zh) | 使用乳酸菌的抗體效價提高劑 | |
EP3069139A4 (en) | BACTERIAL DIAGNOSIS | |
PT3016977T (pt) | Anticorpos humanos anti-il-32 | |
EP2970642A4 (en) | REFRESHING AGENTS | |
GB201322948D0 (en) | Improved formulation | |
GB201314936D0 (en) | Radiolabelling method | |
GB201302036D0 (en) | Diagnosis | |
GB201303158D0 (en) | Ritalinic Acid Immunoassay | |
EP3037100A4 (en) | MEANS TO PREVENT MUSCLE ATROPHY | |
GB201309056D0 (en) | Biosensor | |
AU5187P (en) | WES06 Westringia fruticosa | |
EP2972362A4 (en) | BIOSENSOR OF MULTIPLE BIOMARKERS | |
IL225381A0 (en) | Bacterial immunoassay |